Hepatocyte polyploidization and its association with pathophysiological processes

Cell Death and Disease

Volumn 8, Issue 5, 2017, Pages

  Wang, Min Jun ^a   Chen, Fei ^a   Lau, Joseph TY ^b   Hu, Yi Ping ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANIMAL; GROWTH, DEVELOPMENT AND AGING; HUMAN; LIVER; LIVER CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYPLOIDY;

AGING; ANIMALS; HEPATOCYTES; HUMANS; LIVER; POLYPLOIDY;

EID: 85036565481     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/CDDIS.2017.167     Document Type: Review

References (64)

1. Duncan AW, Dorrell C, Grompe M. Stem cells and liver regeneration. Gastroenterology 2009; 137: 466–481.
2. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276: 60–66.
3. Si-Tayeb K, Lemaigre FP, Duncan SA. Organogenesis and development of the liver. Dev Cell 2010; 18: 175–189.
4. Jungermann K, Kietzmann T. Zonation of parenchymal and nonparenchymal metabolism in liver. Annu Rev Nutr 1996; 16: 179–203.
5. Bucher NLR, Malt RA. Regeneration of Liver and Kidney. Little, Brown: Boston, MA, USA, 1971.
6. Gentric G, Celton-Morizur S, Desdouets C. Polyploidy and liver proliferation. Clin Res Hepatol Gastroenterol 2012; 36: 29–34.
7. Gupta S. Hepatic polyploidy and liver growth control. Semin Cancer Biol 2000; 10: 161–171.
8. Guidotti JE, Bregerie O, Robert A, Debey P, Brechot C, Desdouets C. Liver cell polyploidization: a pivotal role for binuclear hepatocytes. J Biol Chem 2003; 278: 19095–19101.
9. Martin NC, McCullough CT, Bush PG, Sharp L, Hall AC, Harrison DJ. Functional analysis of mouse hepatocytes differing in DNA content: volume, receptor expression and effect of IFN gamma. J Cell Physiol 2002; 191: 138–144.
10. Epstein CJ. Cell size, nuclear content and the development of polyploidy in the mammalian liver. Proc Natl Acad Sci USA 1967; 57: 327–334.
11. Celton-Morizur S, Merlen G, Couton D, Desdouets C. Polyploidy and liver proliferation: central role of insulin signaling. Cell Cycle 2010; 9: 460–466.
12. Celton-Morizur S, Desdouets C. Polyploidization of liver cells. Adv Exp Med Biol 2010; 676: 123–135.
13. Duncan AW, Taylor MH, Hickey RD, Hanlon Newell AE, Lenzi ML, Olson SB et al. The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature 2010; 467: 707–710.
14. Wang MJ, Chen F, Li JX, Liu CC, Zhang HB, Xia Y et al. Reversal of hepatocytes senescence after continuous in vivo cell proliferation. Hepatology 2014; 60: 349–361.
15. Chipchase MD, O'Neill M, Melton DW. Characterization of premature liver polyploidy in DNA repair (Ercc1)-deficient mice. Hepatology 2003; 38: 958–966.
16. Pandit SK, Westendorp B, Nantasanti S, van Liere E, Tooten PC, Cornelissen PW et al. E2F8 is essential for polyploidization in mammalian cells. Nat Cell Biol 2012; 14: 1181–1191.
17. Margall-Ducos G, Celton-Morizur S, Couton D, Brégerie O, Desdouets C. Liver tetraploidization is controlled by a new process of incomplete cytokinesis. J Cell Sci 2007; 120: 3633–3639.
18. Gandillet A, Alexandre E, Holl V, Royer C, Bischoff P, Cinqualbre J et al. Hepatocyte ploidy in normal young rat. Comp Biochem Physiol A Mol Integr Physiol 2003; 134: 665–673.
19. Kudryavtsev BN, Kudryavtseva MV, Sakuta GA, Stein GI. Human hepatocyte polyploidiza-tion kinetics in the course of life cycle. Virchows Arch B Cell Pathol Incl Mol Pathol 1993; 64: 387–393.
20. Duncan AW, Hanlon Newell AE, Smith L, Wilson EM, Olson SB, Thayer MJ et al. Frequent aneuploidy among normal human hepatocytes. Gastroenterology 2012; 142: 25–28.
21. Celton-Morizur S, Merlen G, Couton D, Margall-Ducos G, Desdouets C. The insulin/Akt pathway controls a specific cell division program that leads to generation of binucleated tetraploid liver cells in rodents. J Clin Invest 2009; 119: 1880–1887.
22. Celton-Morizur S, Desdouets C. Polyploidy and liver proliferation. Adv Exp Med Biol 2010; 676: 123–135.
23. Wong JV, Dong P, Nevins JR, Mathey-Prevot B, You L. Network calisthenics: control of E2F dynamics in cell cycle entry. Cell Cycle 2011; 10: 3086–3094.
24. Chen HZ, Ouseph MM, Li J, Pecot T, Chokshi V, Kent L et al. Canonical and atypical E2Fs regulate the mammalian endocycle. Nat Cell Biol 2012; 14: 1192–1202.
25. Nevzorova YA, Tschaharganeh D, Gassler N, Geng Y, Weiskirchen R, Sicinski P et al. Aberrant cell cycle progression and endoreplication in regenerating livers of mice that lack a single E-type cyclin. Gastroenterology 2009; 137: 691–703.
26. Sheahan S, Bellamy CO, Treanor L, Harrison DJ, Prost S. Additive effect of p53, p21 and Rb deletion in triple knockout primary hepatocytes. Oncogene 2004; 23: 1489–1497.
27. Kurinna S, Stratton SA, Coban Z, Schumacher JM, Grompe M, Duncan AW et al. p53 Regulates a mitotic transcription program and determines ploidy in normal mouse liver. Hepatology 2013; 57: 2004–2013.
28. Mayhew CN, Bosco EE, Fox SR, Okaya T, Tarapore P, Schwemberger SJ et al. Liver-specific pRB loss results in ectopic cell cycle entry and aberrant ploidy. Cancer Res 2005; 65: 4568–4577.
29. Diril MK, Ratnacaram CK, Padmakumar VC, Du T, Wasser M, Coppola V et al. Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration. Proc Natl Acad Sci USA 2012; 109: 3826–3831.
30. Minamishima YA, Nakayama K. Recovery of liver mass without proliferation of hepatocytes after partial hepatectomy in Skp2-deficient mice. Cancer Res 2002; 62: 995–999.
31. Kim SH, Jeon Y, Kim HS, Lee JK, Lim HJ, Kang D et al. Hepatocyte homeostasis for chromosome ploidization and liver function is regulated by Ssu72protein phosphatase. Hepatology 2016; 63: 247–259.
32. Hagemann S, Wohlschlaeger J, Bertram S, Levkau B, Musacchio A, Conway EM et al. Loss of Survivin influences liver regeneration and is associated with impaired Aurora B function. Cell Death Differ 2013; 20: 834–844.
33. Li D, Cen J, Chen X, Conway EM, Ji Y, Hui L. Hepatic loss of survivin impairs postnatal liver development and promotes expansion of hepatic progenitor cells in mice. Hepatology 2013; 58: 2109–2121.
34. Hsu SH, Delgado ER, Otero PA, Teng KY, Kutay H, Meehan KM et al. MicroRNA-122 regulates polyploidization in the murine liver. Hepatology 2016; 64: 599–615.
35. Gerlyng P, Abyholm A, Grotmol T, Erikstein B, Huitfeldt HS, Stokke T et al. Binucleation and polyploidization patterns in developmental and regenerative rat liver growth. Cell Prolif 1993; 26: 557–565.
36. Sigal SH, Rajvanshi P, Gorla GR, Erikstein B, Huitfeldt HS, Stokke T et al. Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell aging events. Am J Physiol 1999; 276: G1260–G1272.
37. Turner R, Lozoya O, Wang Y, Cardinale V, Gaudio E, Alpini G et al. Human hepatic stem cell and maturational liver lineage biology. Hepatology 2011; 53: 1035–1045.
38. Schwartz-Arad D, Zajicek G, Bartfeld E. The streaming liver IV: DNA content of the hepatocyte increases with its age. Liver 1989; 9: 93–99.
39. Zindy F, Quelle DE, Roussel MF, Sherr CJ. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 1997; 15: 203–211.
40. Mirzayans R, Andrais B, Scott A, Paterson MC, Murray D. Single-cell analysis of p16(INK4a) and p21(WAF1) expression suggests distinct mechanisms of senescence in normal human and Li-Fraumeni Syndrome fibroblasts. J Cell Physiol 2010; 223: 57–67.
41. Ullah Z, Lee CY, Depamphilis ML. Cip/Kip cyclin-dependent protein kinase inhibitors and the road to polyploidy. Cell Div 2009; 4: 10.
42. Miyaoka Y, Ebato K, Kato H, Arakawa S, Shimizu S, Miyajima A. Hypertrophy and unconventional cell division of hepatocytes underlie liver regeneration. Curr Biol 2012; 22: 1166–1175.
43. Yamada T, Sogawa K, Kim JK, Izumi K, Suzuki Y, Muramatsu Y et al. Increased polyploidy, delayed mitosis and reduced protein phosphatase-1 activity associated with excess copper in the Long Evans Cinnamon rat. Res Commun Mol Pathol Pharmacol 1998; 99: 283–304.
44. Gorla GR, Malhi H, Gupta S. Polyploidy associated with oxidative injury attenuates proliferative potential of cells. J Cell Sci 2001; 114: 2943–2951.
45. Schwarze PE, Saeter G, Armstrong D, Cameron RG, Laconi E, Sarma DS et al. Diploid growth pattern of hepatocellular tumours induced by various carcinogenesis treatments. Carcinogenesis 1991; 12: 325–327.
46. Anti M, Marra G, Rapaccini GL, Rumi C, Bussa S, Fadda G et al. DNA ploidy pattern in human chronic liver diseases and hepatic nodular lesions. Flow cytometric analysis on echo-guided needle liver biopsy. Cancer 1994; 73: 281–288.
47. Seglen PO. DNA ploidy and autophagic protein degradation as determinants of hepatocellular growth and survival. Cell Biol Toxicol 1997; 13: 301–315.
48. Tormos AM, Taléns-Visconti R, Sastre J. Regulation of cytokinesis and its clinical significance. Crit Rev Clin Lab Sci 2015; 52: 159–167.
49. Simerzin A, Zorde-Khvalevsky E, Rivkin M, Adar R, Zucman-Rossi J, Couchy G et al. The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitry. Hepatology 2016; 64: 1623–1636.
50. Bandiera S, Pfeffer S, Baumert TF, Zeisel MB. miR-122–a key factor and therapeutic target in liver disease. J Hepatol 2015; 62: 448–457.
51. He J, Zhao K, Zheng L, Xu Z, Gong W, Chen S et al. Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells. Mol Cancer 2015; 14: 163.
52. Dai D, Liang Y, Xie Z, Fu J, Zhang Y, Zhang Z. Survivin deficiency induces apoptosis and cell cycle arrest in HepG2 hepatocellular carcinoma cells. Oncol Rep 2012; 27: 621–627.
53. Aihara A, Tanaka S, Yasen M, Matsumura S, Mitsunori Y, Murakata A et al. The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma. J Hepatol 2010; 52: 63–71.
54. Hau PM, Siu WY, Wong N, Lai PB, Poon RY. Polyploidization increases the sensitivity to DNA-damaging agents in mammalian cells. FEBS Lett 2006; 580: 4727–4736.
55. Marxer M, Foucar CE, Man WY, Chen Y, Ma HT, Poon RY. Tetraploidization increases sensitivity to Aurora B kinase inhibition. Cell Cycle 2012; 11: 2567–2577.
56. Gentric G, Maillet V, Paradis V, Couton D, L’Hermitte A, Panasyuk G et al. Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease. J Clin Invest 2015; 125: 981–992.
57. Hsu SH, Duncan AW. Pathological polyploidy in liver disease. Hepatology 2015; 62: 968–970.
58. Gentric G, Desdouets C. Liver polyploidy: Dr Jekyll or Mr Hide? Oncotarget 2015; 6: 8430–8431.
59. Schmucker DL. Hepatocyte fine structure during maturation and senescence. J Electron Microsc Tech 1990; 14: 106–125.
60. Asahina K, Shiokawa M, Ueki T, Yamasaki C, Aratani A, Tateno C et al. Multiplicative mononuclear small hepatocytes in adult rat liver: their isolation as a homogeneous population and localization to periportal zone. Biochem Biophys Res Commun 2006; 342: 1160–1167.
61. Lu P, Prost S, Caldwell H, Tugwood JD, Betton GR, Harrison DJ. Microarray analysis of gene expression of mouse hepatocytes of different ploidy. Mamm Genome 2007; 18: 617–626.
62. Anatskaya OV, Vinogradov AE. Genome multiplication as adaptation to tissue survival: evidence from gene expression in mammalian heart and liver. Genomics 2007; 89: 70–80.
63. Anatskaya OV, Vinogradov AE. Somatic polyploidy promotes cell function under stress and energy depletion: evidence fromtissue-specific mammal transcriptome. Funct Integr Genomics 2010; 10: 433–446.
64. Pandit SK, Westendorp B, de Bruin A. Physiological significance of polyploidization in mammalian cells. Trends Cell Biol 2013; 23: 556–566.